Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Taxes (2016 - 2024)

Historic Current Taxes for Sanofi (SNY) over the last 11 years, with Q2 2025 value amounting to $819.5 million.

  • Sanofi's Current Taxes rose 47653.43% to $819.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $819.5 million, marking a year-over-year increase of 47653.43%. This contributed to the annual value of $744.8 million for FY2024, which is 1533.41% up from last year.
  • Per Sanofi's latest filing, its Current Taxes stood at $819.5 million for Q2 2025, which was up 47653.43% from $744.8 million recorded in Q4 2024.
  • In the past 5 years, Sanofi's Current Taxes registered a high of $819.5 million during Q2 2025, and its lowest value of $142.1 million during Q2 2024.
  • For the 5-year period, Sanofi's Current Taxes averaged around $542.1 million, with its median value being $585.6 million (2022).
  • As far as peak fluctuations go, Sanofi's Current Taxes crashed by 6537.38% in 2024, and later soared by 47653.43% in 2025.
  • Over the past 5 years, Sanofi's Current Taxes (Quarter) stood at $353.5 million in 2021, then skyrocketed by 65.67% to $585.6 million in 2022, then rose by 9.68% to $642.3 million in 2023, then increased by 15.95% to $744.8 million in 2024, then rose by 10.03% to $819.5 million in 2025.
  • Its last three reported values are $819.5 million in Q2 2025, $744.8 million for Q4 2024, and $142.1 million during Q2 2024.